It accounts to 60-80% of the UN's annual vaccine procurement and is the source of 60,000 generic drug brands. With this humongous capacity, Indian companies are helping to produce and distribute vaccines to the world turning the 2020 Coronavirus pandemic into an opportunity for strengthening vaccine diplomacy.